Diego Jose Leao de Oliveira MD, Abstract Co-Author: Nothing to Disclose

Rodrigo Sanford Damasceno MD, Presenter: Nothing to Disclose

Tatiana Goyanna Lyra MD, Abstract Co-Author: Nothing to Disclose

Luis Filipe de Souza Godoy MD, Abstract Co-Author: Nothing to Disclose

Marcos Fernando de Lima Docema MD, Abstract Co-Author: Nothing to Disclose

Daniel Delgado, Abstract Co-Author: Nothing to Disclose

Hae W. Lee MD, Abstract Co-Author: Nothing to Disclose

Maria Martin, Abstract Co-Author: Nothing to Disclose

Claudia Da Costa Leite MD, PhD, Abstract Co-Author: Researcher, Guerbet SA

Giovanni Guido Cerri MD, PhD, Abstract Co-Author: Nothing to Disclose

The reader sholude be able to: List the most common acquired toxic-metabolic conditions that manifest as central nervous sytem disturbance;      Reecognize the clinical, laboratory, and imaging findings of these conditions; Perform adequate differential diagnosis for these disorders.

Introducing the most common acquired toxic-metabolic disorder and the symptoms and signs that point to a specific disease or narrow the differential diagnosis Presentation of pathophysiology, clinical features, imaging findings and differential diagnosis of specific disorders: Wernicke's encephalopathy Subacute combined degeneration Osmotic demyelination syndrome Hepatic encephalopathy Hypoglycemia in adults and children Hyperosmolar hyperglycemic state Uremic encephalopathy Drug toxicity: methotrexate Disgnostic algorithm Summary

http://abstract.rsna.org/uploads/2014/14015810/14015810_al96.pdf

Oliveira, D, Damasceno, R, Lyra, T, Godoy, L, Docema, M, Delgado, D, Lee, H, Martin, M, Leite, C, Cerri, G, Acquired Toxic-metabolic Disorders Affecting the Central Nervous System.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14015810.html